Post-induction Measurable Residual Disease Using Multicolor Flow Cytometry Is Strongly Predictive of Inferior Clinical Outcome in the Real-Life Management of Childhood T-Cell Acute Lymphoblastic Leukemia: A Study of 256 Patients

Background: Measurable/minimal residual disease (MRD) status is suggested as a powerful indicator of clinical-outcome in T-cell lymphoblastic leukemia/lymphoma (T-ALL). Contrary to B-cell ALL, reports on T-ALL MRD are limited and mostly based on molecular methods, mainly from developed countries. Mu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Oncol
Asıl Yazarlar: Tembhare, Prashant R., Narula, Gaurav, Khanka, Twinkle, Ghogale, Sitaram, Chatterjee, Gaurav, Patkar, Nikhil V., Prasad, Maya, Badrinath, Yajamanam, Deshpande, Nilesh, Gudapati, Pratyusha, Verma, Shefali, Sanyal, Mahima, Kunjachan, Florence, Mangang, Gunit, Gujral, Sumeet, Banavali, Shripad, Subramanian, Papagudi G.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2020
Konular:
Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7193086/
https://ncbi.nlm.nih.gov/pubmed/32391267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00577
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller